Want to see PGNY full AI Analyst Report?
ART Cycles
Tracks the number of assisted reproductive technology cycles (like IVF) administered through Progyny’s network, which directly drives fee revenue and reflects clinical demand, pricing power, and the company’s relationship with clinics.After a pandemic trough, cycles surged through 2021–2023 and have settled at a much higher, more stable range with clear seasonality (Q2/Q4 strength, Q3 softness). The late‑2025 dip versus mid‑year peaks suggests growth is decelerating toward saturation rather than accelerating—important because future revenue now hinges less on volume expansion and more on conversion rates, pricing per cycle, and employer/member penetration on renewals.
Date | Cycles |
|---|---|
Jun 30, 2026 | 17.00K |
Mar 31, 2026 | 15.65K |
Dec 31, 2025 | 15.93K |
Sep 30, 2025 | 15.98K |
Jun 30, 2025 | 16.94K |
Mar 31, 2025 | 16.16K |
Dec 31, 2024 | 15.84K |
Sep 30, 2024 | 14.91K |
Jun 30, 2024 | 15.56K |
Mar 31, 2024 | 14.80K |